Solid Biosciences Inc (SLDB)
$6.20 -2.97% Close Oct 30, 2026 Live
Solid Biosciences stock today
Solid Biosciences closed at $6.20 on October 30, 2026, down 2.97% on the day. Over the past year it returned +16.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $610 million.
$5.00$7.50$10.00
NovJan 2026MarMayJulSep
| Period | SLDB | S&P 500 (SPY) |
|---|---|---|
| 1 month | -14.2% | -0.9% |
| 3 months | -27.0% | +2.1% |
| Year to date | +9.9% | +11.7% |
| 1 year | +16.8% | +12.4% |
| 3 years | +199.5% | +88.5% |
| 5 years | -79.6% | +76.0% |
Key statistics
- Market value
- $610M
- 52-week range
- $3.93 to $11.15
- Next report
- Nov 2, 2026 (estimated)
About Solid Biosciences
Solid Biosciences develops gene therapies for muscular dystrophy and related genetic diseases.
Sector: Health Care
More on Solid Biosciences
- Returns: what $1,000 became$1,000 five years ago is $203.61 today
No forecast, no recommendation. This page describes Solid Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.